Variability of botulinum toxins: Challenges and opportunities for the future

17Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

Abstract

Botulinum neurotoxins (BoNTs) are the most potent known toxins, and are therefore classified as extremely harmful biological weapons. However, BoNTs are therapeutic drugs that are widely used and have an increasing number of applications. BoNTs show a high diversity and are divided into multiple types and subtypes. Better understanding of the activity at the molecular and clinical levels of the natural BoNT variants as well as the development of BoNT-based chimeric molecules opens the door to novel medical applications such as silencing the sensory neurons at targeted areas and dermal restoration. This short review is focused on BoNTs’ variability and the opportunities or challenges posed for future clinical applications.

Cite

CITATION STYLE

APA

Rasetti-Escargueil, C., Lemichez, E., & Popoff, M. R. (2018, September 13). Variability of botulinum toxins: Challenges and opportunities for the future. Toxins. MDPI AG. https://doi.org/10.3390/toxins10090374

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free